|April 16, 2021
Maine Medical Association Statement on Johnson & Johnson COVID-19 Vaccine Pause
The MMA released the following media statement shortly after Tuesday’s US FDA recommendation, and Governor Mills’ call the pause administration of the Johnson & Johnson COVID vaccine.
News: For Immediate Release
Additional Information Contact:
Dan Morin, Director of Communications & Government Affairs
(207) 838-8613 – mobile
MMA PRESIDENT STATEMENT ON JOHNSON & JOHNSON VACCINE
MANCHESTER, (April 13, 2021) --- Today, the US Food and Drug Administration and Centers for Disease Control and Prevention recommended a pause in the use of the coronavirus vaccine developed by Johnson & Johnson out of an abundance of caution after six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine.
Shortly after, the Maine Center for Disease Control and Prevention announced they were not aware of any reports of these cases in Maine residents. Given this recommendation, the State of Maine is also advising that providers pause administration of the Johnson & Johnson vaccine until the U.S. CDC’s scientific advisory committee has further reviewed the safety data.
MMA President, Karen Saylor, M.D., applauded the move but cautioned, “The reported events are extremely rare, and it has not yet been proven that the vaccine caused the reported blood clots.” She added, “Pausing administration of J&J doses is the right move as all safety concerns should be investigated immediately and thoroughly. This shows our regulatory agencies are doing their job and placing safety first.”
About the Maine Medical Association:
The MMA was founded in 1853 and represents all of Maine's physicians, residents & medical students across all clinical specialties, organizations, and practice settings.
Next Article >
[ return to top ]
ensure delivery of Maine Medicine Weekly Update,
please add 'email@example.com' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm
For more information or to contact us directly, please visit www.mainemed.com | ©